These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10477486)

  • 1. Resolving conflicts: misconceptions and myths in the care of the patient with sickle cell disease.
    Sutton M; Atweh GF; Cashman TD; Davis WT
    Mt Sinai J Med; 1999 Sep; 66(4):282-5. PubMed ID: 10477486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
    Casella JF; Barton BA; Kanter J; Black LV; Majumdar S; Inati A; Wali Y; Drachtman RA; Abboud MR; Kilinc Y; Fuh BR; Al-Khabori MK; Takemoto CM; Salman E; Sarnaik SA; Shah N; Morris CR; Keates-Baleeiro J; Raj A; Alvarez OA; Hsu LL; Thompson AA; Sisler IY; Pace BS; Noronha SA; Lasky JL; de Julian EC; Godder K; Thornburg CD; Kamberos NL; Nuss R; Marsh AM; Owen WC; Schaefer A; Tebbi CK; Chantrain CF; Cohen DE; Karakas Z; Piccone CM; George A; Fixler JM; Singleton TC; Moulton T; Quinn CT; de Castro Lobo CL; Almomen AM; Goyal-Khemka M; Maes P; Emanuele M; Gorney RT; Padgett CS; Parsley E; Kronsberg SS; Kato GJ; Gladwin MT
    JAMA; 2021 Apr; 325(15):1513-1523. PubMed ID: 33877274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of pain due to sickle cell disease.
    Johnson L; Carmona-Bayonas A; Tick L
    J Pain Palliat Care Pharmacother; 2008; 22(1):51-4. PubMed ID: 19042824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID; Woodward M; Reed GW
    Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nurses' attitudes and practices in sickle cell pain management.
    Pack-Mabien A; Labbe E; Herbert D; Haynes J
    Appl Nurs Res; 2001 Nov; 14(4):187-92. PubMed ID: 11699021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: an educational void.
    Solomon LR
    Blood; 2008 Feb; 111(3):997-1003. PubMed ID: 17940207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency provider analgesic practices and attitudes toward patients with sickle cell disease.
    Glassberg JA; Tanabe P; Chow A; Harper K; Haywood C; DeBaun MR; Richardson LD
    Ann Emerg Med; 2013 Oct; 62(4):293-302.e10. PubMed ID: 23561465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current issues in sickle cell pain and its management.
    Ballas SK
    Hematology Am Soc Hematol Educ Program; 2007; ():97-105. PubMed ID: 18024616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell disease -- when opioids and physicians fail.
    Malach S; Levin T; Saravay S; Martin R; Rao S; Horowitz D
    Gen Hosp Psychiatry; 2002; 24(6):442-7. PubMed ID: 12490348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to the vaso-occlusive crisis in adults with sickle cell disease.
    Yale SH; Nagib N; Guthrie T
    Am Fam Physician; 2000 Mar; 61(5):1349-56, 1363-4. PubMed ID: 10735342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid treatment for acute and chronic pain in patients with sickle cell disease.
    Carroll CP
    Neurosci Lett; 2020 Jan; 714():134534. PubMed ID: 31593753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).
    Tanabe P; Silva S; Bosworth HB; Crawford R; Paice JA; Richardson LD; Miller CN; Glassberg J
    Am J Hematol; 2018 Feb; 93(2):159-168. PubMed ID: 29047145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
    Puri L; Nottage KA; Hankins JS; Anghelescu DL
    Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight Loss as an Effective Strategy to Decrease Opioid Use and Frequency of Vaso-Occlusive Crises in Patients with Sickle Cell Disease.
    Babroudi S; Vesel T
    J Palliat Med; 2021 Apr; 24(4):632-634. PubMed ID: 32881637
    [No Abstract]   [Full Text] [Related]  

  • 17. Variations in pediatric emergency medicine physician practices for intravenous fluid management in children with sickle cell disease and vaso-occlusive pain: A single institution experience.
    Carden MA; Patil P; Ahmad ME; Lam WA; Joiner CH; Morris CR
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28766843
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of sickle cell pain.
    Marlowe KF; Chicella MF
    Pharmacotherapy; 2002 Apr; 22(4):484-91. PubMed ID: 11939683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain management in adults with sickle cell disease in a medical center emergency department.
    Solomon LR
    J Natl Med Assoc; 2010 Nov; 102(11):1025-32. PubMed ID: 21141290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
    Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
    Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.